CN105853515A - Traditional Chinese medicine composition for treating acne and preparation method thereof - Google Patents

Traditional Chinese medicine composition for treating acne and preparation method thereof Download PDF

Info

Publication number
CN105853515A
CN105853515A CN201610165238.9A CN201610165238A CN105853515A CN 105853515 A CN105853515 A CN 105853515A CN 201610165238 A CN201610165238 A CN 201610165238A CN 105853515 A CN105853515 A CN 105853515A
Authority
CN
China
Prior art keywords
chinese medicine
ethanol
extract
radix
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610165238.9A
Other languages
Chinese (zh)
Inventor
吕爱平
张戈
吕诚
赵宁
王茂林
姜淼
何小鹃
谭勇
张弛
李立
白菁安
党蕾
刘彪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Basic Medical Sciences of CAMS
Original Assignee
Institute of Basic Medical Sciences of CAMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Basic Medical Sciences of CAMS filed Critical Institute of Basic Medical Sciences of CAMS
Priority to CN201610165238.9A priority Critical patent/CN105853515A/en
Publication of CN105853515A publication Critical patent/CN105853515A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating acne. The traditional Chinese medicine composition is composed of Chinese rhubarb extract and dandelion extract and can be made into any pharmaceutically acceptable oral dosage form, including a tablet, a capsule, a granule, a pill and syrup. According to the invention, the raw materials are simple; cost is reduced compared with other compositions for treating acne; a specific traditional Chinese medicine extraction method is employed, so the recovery rates of effective components in the traditional Chinese medicines are increased; and the traditional Chinese medicine composition has improved treatment effect and small toxic and side effect.

Description

A kind of Chinese medicine composition treating acne and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine composition treating acne and preparation method thereof, belong to doctor Medicine field.
Background technology
Acne is one of modal disease of department of dermatologry, is mainly in adolescence, is again comedo , acne, folliculitis, be generally apt to occur in face, cervical region.Clinical with Whiteheads, inflammatory Pimple, pustule, tuberosity, cyst etc. are main performance, and during outbreak, affected part is often accompanied by acute inflammation Disease and pain reaction.Contact dermatitis (ACD) is skin or mucosa single or multiple connects After touching exogenous material, the struvite disease that the position beyond contact site even contacts occurs Sick.Owing to patient is difficult to thoroughly depart from corresponding contact virulence factor, therefore primary disease is the most anti- Recurrence is made, and prolonged does not heals.
The medicine of quality acne is a lot of on the market, and dragons and fishes jumbled together, and great majority are all to take stopgap measures not control This, the temporary transient acne having restrained surface, and also side effect is very big, also has bigger depending on Lai Xing.
Summary of the invention
It is an object of the invention to provide a kind of Chinese medicine composition treating acne and preparation side thereof Method, is made up of extract from Radix Et Rhizoma Rhei and Herba Taraxaci respectively, and curative effect is more excellent, more stable , and have no side effect.
A kind of Chinese medicine composition treating acne, including following traditional Chinese medicine raw: Radix Et Rhizoma Rhei, Pu Gong English.
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 3-7 part, Herba Taraxaci extract 7-9 part.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 60-70 DEG C of the acetone adding 5-7 times of quality is heated to reflux 50- 70 minutes, filter, obtain filtrate;
(2) the 1/5-of filtrate decompression recycling design to volume 1/3, obtain concentrated solution, then use concentrated solution 2- The petroleum ether extraction of 3 times of volumes, obtains petroleum ether part;
(3) DM-301 macroporous adsorptive resins in petroleum ether part, upper column flow rate is 1.8- 2.2BV/h, then by the methanol-eluted fractions of 3BV, elution flow rate is 1.8- 2.2BV/h, collects eluent;
(4) eluent being evaporated to relative density is 1.05- The extractum of 1.09, is Radix Et Rhizoma Rhei extract
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 7-9 times of quality 50% ethanol 80- 90 DEG C of heating and refluxing extraction 80-120 minute, filter, obtain filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.4- 1.6BV/h, with the water of 4BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV , elution flow rate is 1.4-1.6BV/h, collects 50% ethanol elution;
(3) 50% ethanol elution regulation pH to 5-6, upper DA- 201 macroporous adsorptive resins, upper column flow rate is 1.8- 2.2BV/h, then with the water of 4BV, 50% ethanol of 2BV, the 70% ethanol gradient successively of 1BV is washed De-, elution flow rate is 1.8-2.2BV/h, collects 70% ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), D101 macroporous adsorbent resin and the DA-of step (3) The volume ratio of 201 macroporous adsorbent resins is 1:1:1, and height and the diameter ratio of 2 resin columns are all 4:0.8。
Described peroral dosage form is: tablet, capsule, granule, pill, syrup.
Raw material of the present invention is simple, compared with the Chinese medicine composition of other treatment acne, reduces Cost, have employed specific Traditional Chinese medicine extraction method simultaneously, has extracted the effective ingredient of acne , improve therapeutic effect, and toxic and side effects be little.
Specific embodiment:
Embodiment 1:
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 3 parts, Herba Taraxaci extract 7 parts.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 60 DEG C of the acetone adding 5 times of quality is heated to reflux 50 minutes, mistake Filter, obtains filtrate;
(2) the 1/5 of filtrate decompression recycling design to volume, concentrated solution is obtained, then with concentrating The petroleum ether extraction of 2 times of volumes of liquid, obtains petroleum ether part;
(3) DM-in petroleum ether part 301 macroporous adsorptive resins, upper column flow rate is 1.8BV/h, then by the methanol-eluted fractions of 3BV, washes Separation of flow speed is 1.8BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 1.05, is Radix Et Rhizoma Rhei and carries Take thing
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 80 DEG C of heating and refluxing extraction of 7 times of quality 50% ethanol 80 points Clock, filters, obtains filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.4BV/h, with 4 The water of BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1 .4BV/h, 50% ethanol elution is collected;
(3) 50% ethanol elution regulation pH to 5-6, upper DA- 201 macroporous adsorptive resins, upper column flow rate is 1.8BV/h, then with the water of 4BV, the 50% of 2BV Ethanol, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 1.8BV/h, collects 70% Ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), D101 macroporous adsorbent resin and the DA-of step (3) The volume ratio of 201 macroporous adsorbent resins is 1:1:1, and height and the diameter ratio of 2 resin columns are all 4:0.8。
Embodiment 2:
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 5 parts, Herba Taraxaci extract 8 parts.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 65 DEG C of the acetone adding 6 times of quality is heated to reflux 60 minutes, mistake Filter, obtains filtrate;
(2) the 1/4 of filtrate decompression recycling design to volume, concentrated solution is obtained, then with concentrating The petroleum ether extraction of 2.5 times of volumes of liquid, obtains petroleum ether part;
(3) DM-in petroleum ether part 301 macroporous adsorptive resins, upper column flow rate is 2.0BV/h, then by the methanol-eluted fractions of 3BV, washes Separation of flow speed is 2.0BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 1.07, is Radix Et Rhizoma Rhei and carries Take thing
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 85 DEG C of heating and refluxing extraction 100 of 8 times of quality 50% ethanol Minute, filter, obtain filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.5BV/h, with 4 The water of BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1 .5BV/h, 50% ethanol elution is collected;
(3) 50% ethanol elution regulation pH to 5-6, upper DA- 201 macroporous adsorptive resins, upper column flow rate is 2.0BV/h, then with the water of 4BV, the 50% of 2BV Ethanol, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 2.0BV/h, collects 70% Ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), D101 macroporous adsorbent resin and the DA-of step (3) The volume ratio of 201 macroporous adsorbent resins is 1:1:1, and height and the diameter ratio of 2 resin columns are all 4:0.8。
Embodiment 3:
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 7 parts, Herba Taraxaci extract 9 parts.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 70 DEG C of the acetone adding 7 times of quality is heated to reflux 70 minutes, mistake Filter, obtains filtrate;
(2) the 1/3 of filtrate decompression recycling design to volume, concentrated solution is obtained, then with concentrating The petroleum ether extraction of 3 times of volumes of liquid, obtains petroleum ether part;
(3) DM-in petroleum ether part 301 macroporous adsorptive resins, upper column flow rate is 2.2BV/h, then by the methanol-eluted fractions of 3BV, washes Separation of flow speed is 2.2BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 0.09, is Radix Et Rhizoma Rhei and carries Take thing
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 90 DEG C of heating and refluxing extraction 120 of 9 times of quality 50% ethanol Minute, filter, obtain filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.6BV/h, with 4 The water of BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1 .6BV/h, 50% ethanol elution is collected;
(3) 50% ethanol elution regulation pH to 5-6, upper DA- 201 macroporous adsorptive resins, upper column flow rate is 2.2BV/h, then with the water of 4BV, the 50% of 2BV Ethanol, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 2.2BV/h, collects 70% Ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), D101 macroporous adsorbent resin and the DA-of step (3) The volume ratio of 201 macroporous adsorbent resins is 1:1:1, and height and the diameter ratio of 2 resin columns are all 4:0.8。
Embodiment 4:
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 10 parts, Herba Taraxaci extract 5 parts.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 75 DEG C of the acetone adding 8 times of quality is heated to reflux 40 minutes, mistake Filter, obtains filtrate;
(2) the 1/2 of filtrate decompression recycling design to volume, concentrated solution is obtained, then with concentrating The petroleum ether extraction of 4 times of volumes of liquid, obtains petroleum ether part;
(3) DM-in petroleum ether part 301 macroporous adsorptive resins, upper column flow rate is 1.5BV/h, then by the methanol-eluted fractions of 3BV, washes Separation of flow speed is 1.5BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 1.10, is Radix Et Rhizoma Rhei and carries Take thing
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 75 DEG C of heating and refluxing extraction 140 of 6 times of quality 50% ethanol Minute, filter, obtain filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.8BV/h, with 4 The water of BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1 .8BV/h, 50% ethanol elution is collected;
(3) 50% ethanol elution regulation pH to 5-6, upper DA- 201 macroporous adsorptive resins, upper column flow rate is 1.5BV/h, then with the water of 4BV, the 50% of 2BV Ethanol, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 1.5BV/h, collects 70% Ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), D101 macroporous adsorbent resin and the DA-of step (3) The volume ratio of 201 macroporous adsorbent resins is 1:1:1, and height and the diameter ratio of 2 resin columns are all 4:0.8。
Embodiment 5:
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 4 parts, Herba Taraxaci extract 7 parts.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 60 DEG C of the acetone adding 6 times of quality is heated to reflux 55 minutes, mistake Filter, obtains filtrate;
(2) the 1/5 of filtrate decompression recycling design to volume, concentrated solution is obtained, then with concentrating The petroleum ether extraction of 3 times of volumes of liquid, obtains petroleum ether part;
(3) D101 macroporous adsorptive resins in petroleum ether part, upper column flow rate is 1.9BV/ H, then by the methanol-eluted fractions of 3BV, elution flow rate is 1.9BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 1.06, is Radix Et Rhizoma Rhei and carries Take thing
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 90 DEG C of heating and refluxing extraction of 9 times of quality 50% ethanol 90 points Clock, filters, obtains filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.4BV/h, with 4 The water of BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1 .4BV/h, 50% ethanol elution is collected;
(3) 50% ethanol elution regulation pH to 5-6, upper DA- 201 macroporous adsorptive resins, upper column flow rate is 2.1BV/h, then with the water of 4BV, the 50% of 2BV Ethanol, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 2.1BV/h, collects 70% Ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), D101 macroporous adsorbent resin and the DA-of step (3) The volume ratio of 201 macroporous adsorbent resins is 1:1:1, and height and the diameter ratio of 2 resin columns are all 4:0.8。
Embodiment 6:
A kind of Chinese medicine composition treating acne, including the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 6 parts, Herba Taraxaci extract 8 parts.
A kind of Chinese medicine composition treating acne, preparation method is: Radix Et Rhizoma Rhei extract and Pu are public Peroral dosage form described on any pharmaceutics is made after English extract mix homogeneously.
The extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 65 DEG C of the acetone adding 6 times of quality is heated to reflux 65 minutes, mistake Filter, obtains filtrate;
(2) the 1/4 of filtrate decompression recycling design to volume, concentrated solution is obtained, then with concentrating The petroleum ether extraction of 2.5 times of volumes of liquid, obtains petroleum ether part;
(3) DM-in petroleum ether part 301 macroporous adsorptive resins, upper column flow rate is 2.1BV/h, then by the methanol-eluted fractions of 3BV, washes Separation of flow speed is 2.1BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 1.08, is Radix Et Rhizoma Rhei and carries Take thing
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C.
Wherein, petroleum ether and DM-in step (3) The volume ratio of 301 macroporous adsorbent resins is 1:1, and the height of resin column and diameter are than for 4:1.
The extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 85 DEG C of heating and refluxing extraction 110 of 8 times of quality 90% ethanol Minute, filter, obtain filtrate;
(2) upper for filtrate DA- 201 macroporous adsorptive resins, upper column flow rate is 1.6BV/h, by the water of 4BV, 50% second of 2BV Alcohol, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1.6BV/h, collects 50% second Alcohol eluen;
(3) 50% ethanol elution regulation pH to 5- 6, upper D101 macroporous adsorptive resins, upper column flow rate is 1.9BV/h, then with the water of 4BV, 50% ethanol of 2BV, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 1.9BV/h, Collect 70% ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci Extract.
Wherein, the filtrate of step (2), DA- The volume ratio of the D101 macroporous adsorbent resin of 201 macroporous adsorbent resins and step (3) is 1:1:1 , the height of 2 resin columns and diameter are 4:0.8 than all.
Embodiment 7:
Using conventional fabrication process, mixed extract of the present invention can be made into any pharmaceutics Upper described peroral dosage form, such as tablet, capsule, granule, pill, syrup.
Remaining is with any one in embodiment 1-6.
Embodiment 8:
Will be by embodiment 1- The extract of 3 mix homogeneously prepared, according to the operational approach of conventional tablet, adds medicinal auxiliary Material, by each component mix homogeneously, wet granulation, sieves, and uses conventional tablet to prepare method pressure Sheet makes tablet, and the content of the most each component is as follows:
Remaining is with any one in embodiment 1-6.
Embodiment 9:
Will be by embodiment 1- The extract of 3 mix homogeneously prepared, according to the operational approach of conventional capsule, adds medicinal Adjuvant, by each component mix homogeneously, pelletizes, and uses conventional capsule to prepare method filling and makes Capsule, the content of the most each component is as follows:
Remaining is with any one in embodiment 1-6.
Embodiment 10:
Will be by embodiment 1- The extract of 3 mix homogeneously prepared, according to the operational approach of conventional syrup, ethanol precipitates 1- 2 times, filtering, concentrate, aqueous precipitation, filter, add pharmaceutic adjuvant, filter, subpackage goes out Bacterium, uses conventional syrup to prepare method and prepares oral liquid, and the content of the most each component is as follows:
Remaining is with any one in embodiment 1-6.
Animal clinical study:
On the impact of family's rabbit ear acne caused by coal tar:
Take new zealand rabbit 48, male and female half and half, be divided into 8 groups by body weight and sex Stochastic Equilibrium, I.e. Normal group, model control group, embodiment 1- 6 groups, often group 6.After packet in addition to Normal group, remaining is respectively organized all in auris dextra medial surface Syrinx opening part 3cm × 3cm scope, is coated with dense liquor carbonis detergens 1 time every day, and each 0.6 Ml, continuous 4 weeks, Normal group rabbit smeared olive oil 0.6ml at same position.4 weeks After, smear coal tar person all has ear to thicken, coarse, black keratotic plug etc. changes.Embodiment 1- 6 groups start by gastric infusion respectively, and administration volume is 2g/kg, Normal group, model pair Distilled water 5g/kg is given with method gavage according to group, every day 1 time, continuous 2 weeks.It is administered simultaneously by front State modeling method and continue modeling.Every El, in addition to being administered, answers local at perusal rabbit ear modeling The change of skin, ear thickness, hardness, rough degree, follicular orifice are with or without black keratotic plug etc..Inspection Survey index: 1. ear acne formed intensity: last be administered after 1 H, measures each group of rabbit left and right ear same position thickness with spiral micrometer, subtracts with auris dextra thickness The difference removing left ear thickness forms intensity as acne;2. ear acne response strength: after measurement With 10 Each group of rabbit left and right ear same position auricle laid by mm metal card punch, weighs, with auris dextra sheet Quality deducts left auricle quality as acne response strength;3. pathological observation: stay after weighing Each group rabbit right auricle, 10% formaldehyde is fixed, and carries out pruning, embedding by pathological examination program , section, HE dyeing, mounting etc., last microscopy, part specimen photomicrograph, observer Rabbit auris dextra tissue epidermis, high dermis iuntercellular and cellular morphology change, cell infiltration etc. Abnormal change.
Experimental acne histology's criterion :- For without acne;+ for the slight keratinization of hair follicle, hypertrophy that sebaceous gland is slight or without obvious hypertrophy;++ for Hair follicle area slightly expands, and the keratinization material of moderate seen from infundibulum, sebaceous gland slightly increases Raw;+++ substantially expanding for hair follicle area, inside have substantial amounts of keratinization material, sebaceous gland diameter is bright Aobvious increase.
Table 1 present invention acne experimental on the rabbit ear histological impact of pathology
Table 2 present invention is on the impact of family's rabbit ear acne caused by coal tar
Result shows: in embodiment of the present invention 1- The shadow of family's rabbit ear acne caused by the 3 acne histological impacts of pathology experimental on the rabbit ear and coal tar Ring and be all substantially better than embodiment 4 groups (technological parameter is different), 5 groups of (carrying of Radix Et Rhizoma Rhei of embodiment Taking technique is different), embodiment 6 groups (extraction process of Herba Taraxaci is different), it is seen that technique is joined Number, extraction process all effective ingredient and treatments to prepared extract drugs of Radix Et Rhizoma Rhei and Herba Taraxaci Effect has an impact, and therefore present invention employs carrying of specific technological parameter, Radix Et Rhizoma Rhei and Herba Taraxaci Taking technique, could prepare the medicine for the treatment of acne evident in efficacy.

Claims (6)

1. treat a Chinese medicine composition for acne, it is characterized by: include following traditional Chinese medicine raw: Radix Et Rhizoma Rhei, Herba Taraxaci.
2. treat a Chinese medicine composition for acne, it is characterized by: include the raw material of Chinese medicine of following masses number: Radix Et Rhizoma Rhei extract 3-7 part, Herba Taraxaci extract 7-9 part.
A kind of Chinese medicine composition treating acne, is characterized by: preparation method is: make peroral dosage form described on any pharmaceutics after Radix Et Rhizoma Rhei extract and Herba Taraxaci extract mix homogeneously.
A kind of Chinese medicine composition treating acne, is characterized by: the extracting method of described Radix Et Rhizoma Rhei extract is:
(1) being pulverized by Radix Et Rhizoma Rhei, 60-70 DEG C of the acetone adding 5-7 times of quality is heated to reflux 50-70 minute, filters, obtains filtrate;
(2) the 1/5-1/3 of filtrate decompression recycling design to volume, obtain concentrated solution, then the petroleum ether extraction with 2-3 times of volume of concentrated solution, obtain petroleum ether part;
(3) DM-301 macroporous adsorptive resins in petroleum ether part, upper column flow rate is 1.8-2.2BV/h, then by the methanol-eluted fractions of 3BV, elution flow rate is 1.8-2.2BV/h, collects eluent;
(4) eluent is evaporated to the extractum that relative density is 1.05-1.09, is Radix Et Rhizoma Rhei extract;
Wherein, in step (2), the boiling range specification of petroleum ether is 60-90 DEG C;
Wherein, in step (3), the volume ratio of petroleum ether and DM-301 macroporous adsorbent resin is 1:1, and the height of resin column and diameter are than for 4:1.
A kind of Chinese medicine composition treating acne, is characterized by: the extracting method of described Herba Taraxaci extract is:
(1) Herba Taraxaci is pulverized, add 7-9 times of quality 50% 80-90 DEG C of heating and refluxing extraction 80-120 minute of ethanol, filter, obtain filtrate;
(2) upper for filtrate D101 macroporous adsorptive resins, upper column flow rate is 1.4-1.6BV/h, and with the water of 4BV, 50% ethanol of 2BV, the 95% ethanol gradient elution successively of 1BV, elution flow rate is 1.4-1.6BV/h, collects 50% ethanol elution;
(3) 50% ethanol elution regulation pH to 5-6, upper DA-201 macroporous adsorptive resins, upper column flow rate is 1.8-2.2BV/h, again with the water of 4BV, 50% ethanol of 2BV, the 70% ethanol gradient elution successively of 1BV, elution flow rate is 1.8-2.2BV/h, collects 70% ethanol elution;
(4) 70% ethanol elution decompression and solvent recovery to the 1/2 of volume, it is Herba Taraxaci extract;
Wherein, the volume ratio of the DA-201 macroporous adsorbent resin of the filtrate of step (2), D101 macroporous adsorbent resin and step (3) is 1:1:1, and the height of 2 resin columns and diameter are 4:0.8 than all.
A kind of Chinese medicine composition treating acne, is characterized by: described peroral dosage form is: tablet, capsule, granule, pill, syrup.
CN201610165238.9A 2016-03-22 2016-03-22 Traditional Chinese medicine composition for treating acne and preparation method thereof Pending CN105853515A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610165238.9A CN105853515A (en) 2016-03-22 2016-03-22 Traditional Chinese medicine composition for treating acne and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610165238.9A CN105853515A (en) 2016-03-22 2016-03-22 Traditional Chinese medicine composition for treating acne and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105853515A true CN105853515A (en) 2016-08-17

Family

ID=56625509

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610165238.9A Pending CN105853515A (en) 2016-03-22 2016-03-22 Traditional Chinese medicine composition for treating acne and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105853515A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111297952A (en) * 2020-02-23 2020-06-19 王桂娟 External-use medicine prescription for treating allergic dermatitis and acne, use method and atomization equipment thereof
CN113425787A (en) * 2021-06-18 2021-09-24 南方医科大学 Composition for preventing and treating acne and preparation method and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101147767A (en) * 2006-09-22 2008-03-26 广州王老吉药业股份有限公司 Medicinal composition for treating acne and its capsule preparation method
CN101147766A (en) * 2006-09-22 2008-03-26 广州王老吉药业股份有限公司 Medicinal composition for treating acne and preparation process thereof
CN101637526A (en) * 2008-07-28 2010-02-03 内蒙古医学院 Drug for curing acne
CN102178893A (en) * 2011-04-27 2011-09-14 贾晋科 Composite medicine for treating acne
CN102716268A (en) * 2012-06-18 2012-10-10 荣成市商贸城卫生所 Traditional Chinese medicine composite for treating acne
CN102935129A (en) * 2012-09-30 2013-02-20 广西梧州三鹤药业有限公司 Pharmaceutical composition for cleaning and removing acne and preparation method of pharmaceutical composition
CN102935128A (en) * 2011-12-14 2013-02-20 江西普正制药有限公司 Preparation method for heat-clearing acne capsule
CN103099904A (en) * 2013-02-26 2013-05-15 苏州市洋海电子有限公司 Traditional Chinese medicine preparation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101147767A (en) * 2006-09-22 2008-03-26 广州王老吉药业股份有限公司 Medicinal composition for treating acne and its capsule preparation method
CN101147766A (en) * 2006-09-22 2008-03-26 广州王老吉药业股份有限公司 Medicinal composition for treating acne and preparation process thereof
CN101637526A (en) * 2008-07-28 2010-02-03 内蒙古医学院 Drug for curing acne
CN102178893A (en) * 2011-04-27 2011-09-14 贾晋科 Composite medicine for treating acne
CN102935128A (en) * 2011-12-14 2013-02-20 江西普正制药有限公司 Preparation method for heat-clearing acne capsule
CN102716268A (en) * 2012-06-18 2012-10-10 荣成市商贸城卫生所 Traditional Chinese medicine composite for treating acne
CN102935129A (en) * 2012-09-30 2013-02-20 广西梧州三鹤药业有限公司 Pharmaceutical composition for cleaning and removing acne and preparation method of pharmaceutical composition
CN103099904A (en) * 2013-02-26 2013-05-15 苏州市洋海电子有限公司 Traditional Chinese medicine preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111297952A (en) * 2020-02-23 2020-06-19 王桂娟 External-use medicine prescription for treating allergic dermatitis and acne, use method and atomization equipment thereof
CN113425787A (en) * 2021-06-18 2021-09-24 南方医科大学 Composition for preventing and treating acne and preparation method and application thereof

Similar Documents

Publication Publication Date Title
Yang et al. Radix Bupleuri: a review of traditional uses, botany, phytochemistry, pharmacology, and toxicology
JP5184090B2 (en) Pharmaceutical composition for treating and / or preventing hyperlipidemia, its production method and its use
CN105853515A (en) Traditional Chinese medicine composition for treating acne and preparation method thereof
CN102258742B (en) Chinese medicinal medicine composition for treating depression and preparation method thereof
Zhao et al. Large dose means significant effect–dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats
CN103655791B (en) A kind of lotus leaf-based preparation for treating phlegm and blood stasis simultaneously and application thereof
CN1985891B (en) Compound Chinese medicine preparation with liver protecting function and its preparing process
CN108434399A (en) A kind of Chinese medicine composition and preparation method of anti-curing oncoma
CN104873687A (en) Traditional Chinese medicine composition for treating children attention deficit hyperactivity disorder
CN103599295A (en) Traditional Chinese medicine for treating fatty liver
CN100409869C (en) Externally-applied medicinal liquid for treating dermatosis
CN100344299C (en) Medicine for treating woman's dysmenorrhea and preparing process thereof
CN102940709B (en) Medicine composition for treating gout
CN105287721A (en) Chinese herbal compound for treating arthritis, cataplasm preparation of Chinese herbal compound for treating arthritis and method for preparing cataplasm preparation
CN100500183C (en) Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease
CN102552729B (en) Medicament for treating mesangial proliferative glomerulonephritis
CN102940680B (en) Medicine composition for treating cardia-cerebrovascular diseases
CN105616839B (en) A kind of herbal medicine efficacy component compound with antidepressant effect
CN104224888A (en) Traditional Chinese medicinal composition used for strengthening bone
CN100369622C (en) Blood fat-reducing Chinese medicine and preparation method thereof
CN104095912B (en) Treat the preparation method of the Chinese patent drug of rheumatism bone disease
CN107648397B (en) Traditional Chinese medicine composition for treating liver-kidney yin deficiency and preparation method and application thereof
CN106109862A (en) A kind of Rhizoma Paridis extract treating viral influenza
CN105663192A (en) Novel application of notoginseng in preparation of medicine for treating and/or preventing prostatitis
CN105131070A (en) Method for directly extracting panasadiol saponins from pseudo-ginseng

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160817

RJ01 Rejection of invention patent application after publication